Dr. Noth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Hospital Dr
Fl 2
Charlottesville, VA 22908Phone+1 434-924-5219Fax+1 434-244-7509
Education & Training
- University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
- University of California Davis HealthResidency, Internal Medicine, 1992 - 1995
- University of Arizona College of MedicineClass of 1992
Certifications & Licensure
- AZ State Medical License 1995 - Present
- CA State Medical License 1993 - Present
- VA State Medical License 2018 - 2026
- IL State Medical License 1996 - 2020
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations Start of enrollment: 2005 Jan 01
- A Study of the Natural Progression of Interstitial Lung Disease (ILD) Start of enrollment: 2005 Sep 01
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis Start of enrollment: 2007 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsRandomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.Richard B. Moss, Nicole Mayer-Hamblett, Jeffrey S. Wagener, Cori L. Daines, Kathryn A Hale
Pediatric Pulmonology. 2005-03-01 - 175 citationsFuture directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.Timothy S. Blackwell, Andrew M. Tager, Zea Borok, Bethany B. Moore, David A. Schwartz
American Journal of Respiratory and Critical Care Medicine. 2014-01-15 - 739 citationsAcute Exacerbations of Idiopathic Pulmonary FibrosisHarold R. Collard, Bethany B. Moore, Kevin R. Flaherty, Kevin K. Brown, Robert J. Kaner
American Journal of Respiratory and Critical Care Medicine. 2007-10-01
Other
- Management of the patient with severe COPD and cardiovascular diseaseNoth I, Schmidt GA
http://www.uptodate.com/contents/management-of-the-patient-with-severe-copd-and-cardiovascular-disea
UpToDate, Wolters Kluwer Health - 2013-02-12
Press Mentions
- iTHRIV Backs Promising Researchers to Improve Patient CareJune 10th, 2024
- Antibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyJune 4th, 2021
- Ofev Doubles the Chance of Improving or Stabilizing IPFMay 26th, 2017
- Join now to see all
Grant Support
- Genome-Wide Association And EXON Sequencing Study In IPFNational Heart, Lung, And Blood Institute2009–2010
- Combination Therapy In IPFNational Heart, Lung, And Blood Institute2005–2009
- FP And Salmeterol In Preventing COPD ExacerbationsNational Center For Research Resources2006–2007
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: